6DDP

Mycobacterium tuberculosis Dihydrofolate Reductase complexed with beta-NADPH and 3'-[(2R)-4-(2,4-diamino-6-ethylpyrimidin-5-yl)but-3-yn-2-yl]-5'-methoxy[1,1'-biphenyl]-4-carboxylic acid

Summary for 6DDP

• Entry DOI: 10.2210/pdb6ddp/pdb
• Related: 5JA3
• Descriptor: Dihydrofolate reductase, NADPH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE, 3'-[(2R)-4-(2,4-diamino-6-ethylpyrimidin-5-yl)but-3-yn-2-yl]-5'-methoxy[1,1'-biphenyl]-4-carboxylic acid, ... (4 entities in total)
• Functional Keywords: dhfr, antifolate, oxidoreductase-oxidoreductase inhibitor complex, oxidoreductase/oxidoreductase inhibitor
• Biological source: Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv)
• Total number of polymer chains: 4
• Total formula weight: 75291.54

Authors

Hajian, B.,Wright, D. (deposition date: 2018-05-10, release date: 2018-05-23, Last modification date: 2023-10-11)

• Primary citation: Hajian, B.,Scocchera, E.,Shoen, C.,Krucinska, J.,Viswanathan, K.,G-Dayanandan, N.,Erlandsen, H.,Estrada, A.,Mikusova, K.,Kordulakova, J.,Cynamon, M.,Wright, D.; Drugging the Folate Pathway in Mycobacterium tuberculosis: The Role of Multi-targeting Agents.; Cell Chem Biol, 26:781-791.e6, 2019; PubMed: 30930162; DOI: 10.1016/j.chembiol.2019.02.013

Experimental method

X-RAY DIFFRACTION (1.49 Å)